| Using bevacizumab to treat metastatic cancer: UK consensus guidelines. | |
| | |
MedLine Citation:
|
PMID: 21135762 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Concise guidance is lacking for the use of bevacizumab by practicing oncologists. Eight oncologists with experience of bevacizumab were joined by a cardiologist interested in treating hypertension to develop practical guidelines for managing patients receiving bevacizumab, using available clinical data. |
| | |
Authors:
|
D Miles; J Bridgewater; P Ellis; M Harrison; P Nathan; M Nicolson; S Raouf; D Wheatley; C Plummer |
Publication Detail:
|
Type: Consensus Development Conference; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: British journal of hospital medicine (London, England : 2005) Volume: 71 ISSN: 1750-8460 ISO Abbreviation: Br J Hosp Med (Lond) Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-12-07 Completed Date: 2011-03-17 Revised Date: 2011-04-04 |
Medline Journal Info:
|
Nlm Unique ID: 101257109 Medline TA: Br J Hosp Med (Lond) Country: England |
Other Details:
|
Languages: eng Pagination: 670-7 Citation Subset: IM |
Affiliation:
|
Mount Vernon Cancer Centre, London. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibodies, Monoclonal
/
adverse effects*,
therapeutic use Antineoplastic Agents / adverse effects*, therapeutic use Gastrointestinal Diseases / chemically induced Hemorrhage / chemically induced Humans Hypertension / chemically induced, prevention & control Neoplasms / drug therapy* Proteinuria / chemically induced Randomized Controlled Trials as Topic Thromboembolism / chemically induced Vascular Endothelial Growth Factor A / antagonists & inhibitors* Wound Healing / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Antineoplastic Agents; 0/Vascular Endothelial Growth Factor A; 0/bevacizumab |
| Comments/Corrections | |
Erratum In:
|
Br J Hosp Med (Lond). 2011 Feb;72(2):115 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Provision of general paediatric surgery in district general hospitals.
Next Document: Under-representation of the elderly in cancer clinical trials.